A smartphone app designed to help African American smokers quit smoking

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to develop a culturally tailored smartphone application called HealthyCells to assist African American smokers in quitting smoking. The app integrates existing evidence-based interventions and includes culturally relevant content to address specific barriers faced by this population. Participants will use the app during a scheduled quit attempt, receiving prompts for smoking status assessments and rewards for abstinence. The study will evaluate the feasibility and effectiveness of the app in promoting smoking cessation and reducing sedentary behavior among African Americans.

Why it matters

Who can join: the full rules

Study Inclusion Criteria

* Must be 18 years of age or older
* Must identify as Black/African-American
* Must smoke at least 5 cigarettes or cigarette equivalents per day (i.e., cigarettes, cigars, and cigarillos)
* Must be willing to use NRT, a smartphone watch and app, and a smoking cessation counselor to help them quit smoking
* Must be willing to quit smoking within the next 3 weeks
* Must have a CO level of \>6 ppm at app activation.
* Are not currently active, defined as engaging in less than 150 minutes of moderate-intensity aerobic physical activity (e.g., brisk walking) or 75 minutes of vigorous-intensity aerobic physical activity (e.g., running or jogging) each week?

Study Exclusion Criteria

* Does not give permission to administer screening survey
* Does not understand or speak English
* Is not a U.S. citizen or permanent U.S. resident
* Does not use tobacco products
* Does not want to provide SSN, residency status, or OUHSC employee status
* Is not willing to abstain from smoking marijuana or cannabis during their quit attempt
* Is not willing to upload a picture of their tobacco product
* Is not ready to quit smoking as defined by scoring 4 or lower on the readiness to quit ladder
* Has a medical condition that prevents the use of NRT without approval from a healthcare provider
* Has had a serious allergic reaction or side effect from the use of NRT
* Does not give permission to collect contact information
* Must not be currently active, defined as engaging in less than 150 minutes of moderate-intensity aerobic physical activity (e.g., brisk walking) or 75 minutes of vigorous-intensity aerobic physical activity (e.g., running or jogging) each week.

Where it's running

• TSET Health Promotion Research Center
  Oklahoma City, Oklahoma, United States Recruiting

Study contacts

• Study coordinator: Adam C Alexander, PhD
• Email: adam-alexander@ouhsc.edu
• Phone: 1+ (405) 965-0558

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Quitting Matters: a smoking quit program for people living with HIV

  This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.

  Recruiting Wake Forest University Health Sciences · Winston-Salem, North Carolina · NCT06883097

• Smoky Futures: Danish Adolescent Nicotine Use over Time

  This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.

  Recruiting University of Southern Denmark · Copenhagen · NCT07910331

• Nicotine Orodispersible Tablet to Relieve Cravings in Smokers

  A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.

  Recruiting Phase 2 Kenvue Brands LLC · Mississauga, Ontario · NCT07893158

• Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking

  This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.

  Recruiting The University of Hong Kong · Hong Kong · NCT07826884

• NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05

  This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.

  Recruiting at 28 sites Phase 3 Axsome Therapeutics, Inc. · Phoenix, Arizona and 27 other locations · NCT07766655

• AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns

  This study tests whether AI-powered interactive case-based training helps medical interns provide better smoking cessation counseling.

  Recruiting Assiut University · Asyut, Assuit · NCT07650721

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.